+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Genital Herpes Treatment Market by Type of Drugs, Distribution channels, Route of Administration, and Geography - Global Forecast up to 2027

  • PDF Icon

    Report

  • 124 Pages
  • July 2021
  • Region: Global
  • IHR Insights
  • ID: 5446405
10% Free customization
Description Jump to:
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Genital herpes disease is caused due to herpes simplex virus, and it is a sexually transmittable disease or infection (STI). The diagnosis of genital herpes is made from painful blisters on and areas surrounding genitals of both men and women affecting mucus membrane which exist in the body. When compared based on sex, genital herpes is most common among women. Presently no permanent cure has been discovered for genital herpes, which is a chronic condition. Although, medication is available for controlling the triggered symptoms of this disease. The Genital Herpes Treatment Market is anticipated to grow at the rate of 4.1% CAGR by 2027. The key factor projected to accelerate the genital herpes treatment market during the forecast period is escalating demand for effective therapeutic options for the treatment of these infections. Governments worldwide have taken initiatives to address the urgent requirement of better treatment for sexually transmitted infections and to fight the rapid development of antiviral-resistant species, which would support the growth of the genital herpes treatment market. However, the huge expenses incurred in the treatment of genital herpes treatment are likely to hamper the market growth.

Genital Herpes Treatment Market on the basis of Type of Drugs


  • Acyclovir
  • Famciclovir
  • Valacyclovir
  • Others

Genital Herpes Treatment Market on the basis of Distribution channels


  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug stores
  • Online Pharmacies

Genital Herpes Treatment Market on the basis of Route of Administration


  • Oral
  • Topical

Genital Herpes Treatment Market on the basis of Geography


  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

On the basis of types of drugs, the genital herpes treatment market is majorly divided into Acyclovir, Famciclovir, Valacyclovir, and Others. The acyclovir drug type is projected to have a significant share in the market. The acyclovir drugs are considered very effective in suppressing the frequency and quantity of the genital herpes simplex virus. Acyclovir decreases the pain and speeds the healing of sores or blisters in people who had first-time or repeat outbreaks of genital herpes. It works by preventing the spread of the herpes virus in the body. Thus, the above-mentioned advantages of the acyclovir drug are boosting segment growth.

Further on the basis of distribution channel, the genital herpes treatment market has been classified into hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. Among all of the distribution channels, the online pharmacies segment is projected to acquire a maximum share in the market. This is due to the increasing number of online pharmacy websites for the drugs which offer various discounts and growing customer preference for online pharmacies for drugs pushing for the segment growth.

On the basis of route of administration, the genital herpes treatment market is bifurcated into oral and topical. The oral administration route segment has a major share in the market. This is due to customer preference for oral treatment, facilitated by application ease and effectiveness.

As per the market by geography, the market is categorized into North America, Europe, Asia Pacific, and the rest of the world. North America region made a substantial contribution in the market. This is majorly due to the increasing patients’ awareness, better infrastructure, and relatively higher cost of treatment in the region.

The rising prevalence of sexually transmitted diseases, changing socio-cultural openness, and growing awareness are projected to boost the demand for genital herpes treatment over the forecast period. For instance, as per the center for disease control and prevention, approximately 50 million people affected with genital herpes in the U.S. Factors such as increasing diagnosis rate in developing countries and increasing clinical trial of vaccines for genital herpes has also propelled the growth of the global genital herpes treatment market during the forecast period.

The major leading companies of the genital herpes treatment market are Novopharm Ltd., Teva Pharmaceuticals Inc., Dr. Reddy’s Laboratories Ltd., Genocea Biosciences, Mylan Pharmaceuticals Inc., Apotheca Inc., GlaxoSmithKline, Sandoz Inc., Novartis AG, Hospira Inc.

Genital herpes is a disease, which does not have a complete treatment, but the medications are available which are playing a crucial part in suppressing the frequency and quantity of genital herpes among people. Moreover, the awareness has increased among people regarding genital herpes has increased the market demand.
  • The study offers a thorough analysis of the genital herpes treatment market size along with the present trends and forthcoming estimations to describe the impending investment pockets.
  • It also offers the genital herpes treatment market analysis over the forecast period, which is projected to allow the shareholders to benefit from the market opportunities.
  • Comprehensive insights of the four major regions are depicted to determine the potential opportunities.
  • The profiles and dynamic strategies of the major competitors are completely analyzed to understand the competitive outlook and global genital herpes treatment market growth.

Table of Contents

1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Type of Drugs: Market Size & Analysis
5.1. Overview
5.2. Acyclovir
5.3. Famciclovir
5.4. Valacyclovir
5.5. Others
6. Distribution channels: Market Size & Analysis
6.1. Overview
6.2. Hospital Pharmacies
6.3. Retail Pharmacies
6.4. Drug stores
6.5. Online Pharmacies
7. Route of Administration: Market Size & Analysis
7.1. Overview
7.2. Oral
7.3. Topical
8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World
9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. Vendor Profiles
10.1. Novopharm Ltd.
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. Teva Pharmaceuticals Inc.
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. Dr. Reddy’s Laboratories Ltd.
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. Genocea Biosciences
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. Mylan Pharmaceuticals Inc.
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. Apotheca Inc.
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. GlaxoSmithKline
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. Sandoz Inc.
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. Novartis AG
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. Hospira Inc.
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. Analyst Opinion
12. Annexure
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations
List of Tables
Table 1. Global Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Table 2. Global Genital Herpes Treatment Market Value for Acyclovir, by Geography, 2021-2027 (USD Billion)
Table 3. Global Genital Herpes Treatment Market Value for Famciclovir, by Geography, 2021-2027 (USD Billion)
Table 4. Global Genital Herpes Treatment Market Value for Valacyclovir, by Geography, 2021-2027 (USD Billion)
Table 5. Global Genital Herpes Treatment Market Value for Others, by Geography, 2021-2027 (USD Billion)
Table 6. Global Genital Herpes Treatment Market Value, by Distribution Channels, by Geography, 2021-2027 (USD Billion)
Table 7. Global Genital Herpes Treatment Market Value for Hospital Pharmacies, by Geography, 2021-2027 (USD Billion)
Table 8. Global Genital Herpes Treatment Market Value for Retail Pharmacies, by Geography, 2021-2027 (USD Billion)
Table 9. Global Genital Herpes Treatment Market Value for Drug Stores, by Geography, 2021-2027 (USD Billion)
Table 10. Global Genital Herpes Treatment Market Value for Online Pharmacies, by Geography, 2021-2027 (USD Billion)
Table 11. Global Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Table 12. Global Genital Herpes Treatment Market Value for Oral, by Geography, 2021-2027 (USD Billion)
Table 13. Global Genital Herpes Treatment Market Value for Topical, by Geography, 2021-2027 (USD Billion)
Table 14. North America Genital Herpes Treatment Market Value, by Country, 2021-2027 (USD Billion)
Table 15. North America Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Table 16. North America Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Table 17. North America Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Table 18. U.S Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Table 19. U.S Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Table 20. U.S Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Table 21. Canada Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Table 22. Canada Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Table 23. Canada Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Table 24. Europe Genital Herpes Treatment Market Value, by Country, 2021-2027 (USD Billion)
Table 25. Europe Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Table 26. Europe Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Table 27. Europe Genital Herpes Treatment Market Value, Route of Administration, 2021-2027 (USD Billion)
Table 28. Germany Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Table 29. Germany Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Table 30. Germany Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Table 31. U.K Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Table 32. U.K Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Table 33. U.K Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Table 34. France Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Table 35. France Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Table 36. France Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Table 37. Italy Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Table 38. Italy Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Table 39. Italy Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Table 40. Spain Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Table 41. Spain Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Table 42. Spain Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Table 43. Roe Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Table 44. Roe Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Table 45. Roe Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Table 46. Asia Pacific Genital Herpes Treatment Market Value, by Country, 2021-2027 (USD Billion)
Table 47. Asia Pacific Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Table 48. Asia Pacific Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Table 49. Asia Pacific Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Table 50. China Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Table 51. China Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Table 52. China Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Table 53. India Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Table 54. India Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Table 55. India Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Table 56. Japan Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Table 57. Japan Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Table 58. Japan Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Table 59. Rest of APAC Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Table 60. Rest of APAC Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Table 61. Rest of APAC Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Table 62. Rest of World Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Table 63. Rest of World Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Table 64. Rest of World Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Table 65. Novopharm Ltd.: Financials
Table 66. Novopharm Ltd.: Products & Services
Table 67. Novopharm Ltd.: Recent Developments
Table 68. Teva Pharmaceuticals Inc.: Financials
Table 69. Teva Pharmaceuticals Inc.: Products & Services
Table 70. Teva Pharmaceuticals Inc.: Recent Developments
Table 71. Dr. Reddy’S Laboratories Ltd: Financials
Table 72. Dr. Reddy’S Laboratories Ltd: Products & Services
Table 73. Dr. Reddy’S Laboratories Ltd: Recent Developments
Table 74. Genocea Biosciences: Financials
Table 75. Genocea Biosciences: Products & Services
Table 76. Genocea Biosciences: Recent Developments
Table 77. Mylan Pharmaceuticals Inc: Financials
Table 78. Mylan Pharmaceuticals Inc: Products & Services
Table 79. Mylan Pharmaceuticals Inc: Recent Developments
Table 80. Apotheca Inc: Financials
Table 81. Apotheca Inc: Products & Services
Table 82. Apotheca Inc: Recent Developments
Table 83. Glaxosmithkline: Financials
Table 84. Glaxosmithkline: Products & Services
Table 85. Glaxosmithkline: Recent Developments
Table 86. Sandoz Inc: Financials
Table 87. Sandoz Inc: Products & Services
Table 88. Sandoz Inc: Recent Developments
Table 89. Novartis AG: Financials
Table 90. Novartis AG: Products & Services
Table 91. Novartis AG: Recent Developments
Table 92. Hospira Inc: Financials
Table 93. Hospira Inc: Products & Services
Table 94. Hospira Inc: Recent Developments
List of Figures
Chart. 1. Global Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Chart 2. Global Genital Herpes Treatment Market Value for Acyclovir, by Geography, 2021-2027 (USD Billion)
Chart 3. Global Genital Herpes Treatment Market Value for Famciclovir, by Geography, 2021-2027 (USD Billion)
Chart 4. Global Genital Herpes Treatment Market Value for Valacyclovir, by Geography, 2021-2027 (USD Billion)
Chart 5. Global Genital Herpes Treatment Market Value for Others, by Geography, 2021-2027 (USD Billion)
Chart 6. Global Genital Herpes Treatment Market Value, by Distribution Channels, by Geography, 2021-2027 (USD Billion)
Chart 7. Global Genital Herpes Treatment Market Value for Hospital Pharmacies, by Geography, 2021-2027 (USD Billion)
Chart 8. Global Genital Herpes Treatment Market Value for Retail Pharmacies, by Geography, 2021-2027 (USD Billion)
Chart 9. Global Genital Herpes Treatment Market Value for Drug Stores, by Geography, 2021-2027 (USD Billion)
Chart 10. Global Genital Herpes Treatment Market Value for Online Pharmacies, by Geography, 2021-2027 (USD Billion)
Chart 11. Global Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Chart 12. Global Genital Herpes Treatment Market Value for Oral, by Geography, 2021-2027 (USD Billion)
Chart 13. Global Genital Herpes Treatment Market Value for Topical, by Geography, 2021-2027 (USD Billion)
Chart 14. North America Genital Herpes Treatment Market Value, by Country, 2021-2027 (USD Billion)
Chart 15. North America Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Chart 16. North America Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Chart 17. North America Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Chart 18. U.S Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Chart 19. U.S Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Chart 20. U.S Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Chart 21. Canada Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Chart 22. Canada Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Chart 23. Canada Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Chart 24. Europe Genital Herpes Treatment Market Value, by Country, 2021-2027 (USD Billion)
Chart 25. Europe Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Chart 26. Europe Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Chart 27. Europe Genital Herpes Treatment Market Value, Route of Administration, 2021-2027 (USD Billion)
Chart 28. Germany Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Chart 29. Germany Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Chart 30. Germany Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Chart 31. U.K Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Chart 32. U.K Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Chart 33. U.K Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Chart 34. France Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Chart 35. France Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Chart 36. France Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Chart 37. Italy Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Chart 38. Italy Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Chart 39. Italy Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Chart 40. Spain Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Chart 41. Spain Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Chart 42. Spain Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Chart 43. RoE Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Chart 44. RoE Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Chart 45. RoE Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Chart 46. Asia Pacific Genital Herpes Treatment Market Value, by Country, 2021-2027 (USD Billion)
Chart 47. Asia Pacific Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Chart 48. Asia Pacific Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Chart 49. Asia Pacific Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Chart 50. China Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Chart 51. China Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Chart 52. China Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Chart 53. India Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Chart 54. India Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Chart 55. India Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Chart 56. Japan Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Chart 57. Japan Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Chart 58. Japan Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Chart 59. Rest of APAC Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Chart 60. Rest of APAC Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Chart 61. Rest of APAC Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)
Chart 62. Rest of World Genital Herpes Treatment Market Value, by Type of Drugs, 2021-2027 (USD Billion)
Chart 63. Rest of World Genital Herpes Treatment Market Value, by Distribution Channels, 2021-2027 (USD Billion)
Chart 64. Rest of World Genital Herpes Treatment Market Value, by Route of Administration, 2021-2027 (USD Billion)

Companies Mentioned

  • Novopharm Ltd.
  • Teva Pharmaceuticals Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Genocea Biosciences
  • Mylan Pharmaceuticals Inc.
  • Apotheca Inc.
  • GlaxoSmithKline
  • Sandoz Inc.
  • Novartis AG
  • Hospira Inc.

Related Topics

Related Reports

Pharmaceutical Drugs Global Market Report 2024 - Product Image

Pharmaceutical Drugs Global Market Report 2024

  • Report
  • 400 Pages
  • Global
From
Asia-Pacific Pharmaceutical Industry Outlook 2023 - Product Image

Asia-Pacific Pharmaceutical Industry Outlook 2023

  • Report
  • 77 Pages
  • Asia Pacific
From
Drafting Effective Pharmaceutical Patents Training Course (May 13-16, 2024) - Product Image

Drafting Effective Pharmaceutical Patents Training Course (May 13-16, 2024)

  • Conference
  • 4 Days
  • Global
Genital Herpes - Pipeline Insight, 2024 - Product Image

Genital Herpes - Pipeline Insight, 2024

  • Clinical Trials
  • 107 Pages
  • Global
From
Herpes Simplex Virus Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Herpes Simplex Virus Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 108 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.